vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and CF BANKSHARES INC. (CFBK). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $15.7M, roughly 1.2× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -6.8%, a 46.8% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 12.6%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 13.7%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
APYX vs CFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $15.7M |
| Net Profit | $-1.3M | $5.7M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 43.4% |
| Net Margin | -6.8% | 40.0% |
| Revenue YoY | 34.7% | 12.6% |
| Net Profit YoY | 71.9% | 29.9% |
| EPS (diluted) | — | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $15.7M | ||
| Q3 25 | $12.9M | $15.5M | ||
| Q2 25 | $11.4M | $15.6M | ||
| Q1 25 | $9.4M | $14.1M | ||
| Q4 24 | $14.2M | $14.0M | ||
| Q3 24 | $11.5M | $13.1M | ||
| Q2 24 | $12.1M | $12.6M | ||
| Q1 24 | $10.2M | $12.2M |
| Q4 25 | $-1.3M | $5.7M | ||
| Q3 25 | $-2.0M | $2.3M | ||
| Q2 25 | $-3.8M | $5.0M | ||
| Q1 25 | $-4.2M | $4.4M | ||
| Q4 24 | $-4.6M | $4.4M | ||
| Q3 24 | $-4.7M | $4.2M | ||
| Q2 24 | $-6.6M | $1.7M | ||
| Q1 24 | $-7.6M | $3.1M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 43.4% | ||
| Q3 25 | -6.5% | 17.5% | ||
| Q2 25 | -22.6% | 41.1% | ||
| Q1 25 | -32.4% | 39.5% | ||
| Q4 24 | -21.4% | 36.9% | ||
| Q3 24 | -31.6% | 40.4% | ||
| Q2 24 | -45.7% | 15.4% | ||
| Q1 24 | -64.6% | 30.9% |
| Q4 25 | -6.8% | 40.0% | ||
| Q3 25 | -15.4% | 15.1% | ||
| Q2 25 | -33.2% | 32.3% | ||
| Q1 25 | -44.0% | 31.4% | ||
| Q4 24 | -32.5% | 35.2% | ||
| Q3 24 | -40.9% | 32.2% | ||
| Q2 24 | -54.0% | 13.5% | ||
| Q1 24 | -74.0% | 25.2% |
| Q4 25 | — | $0.88 | ||
| Q3 25 | — | $0.36 | ||
| Q2 25 | — | $0.77 | ||
| Q1 25 | — | $0.68 | ||
| Q4 24 | — | $0.68 | ||
| Q3 24 | — | $0.65 | ||
| Q2 24 | $-0.19 | $0.26 | ||
| Q1 24 | $-0.22 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $259.0M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $184.4M |
| Total Assets | $66.8M | $2.1B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $259.0M | ||
| Q3 25 | $25.1M | $272.4M | ||
| Q2 25 | $29.3M | $275.7M | ||
| Q1 25 | $31.0M | $241.0M | ||
| Q4 24 | $31.7M | $235.3M | ||
| Q3 24 | $28.0M | $233.5M | ||
| Q2 24 | $32.7M | $241.8M | ||
| Q1 24 | $37.3M | $236.9M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $184.4M | ||
| Q3 25 | $5.8M | $179.3M | ||
| Q2 25 | $7.3M | $177.0M | ||
| Q1 25 | $10.5M | $172.7M | ||
| Q4 24 | $14.2M | $168.4M | ||
| Q3 24 | $11.0M | $164.0M | ||
| Q2 24 | $14.7M | $159.6M | ||
| Q1 24 | $20.3M | $158.0M |
| Q4 25 | $66.8M | $2.1B | ||
| Q3 25 | $57.4M | $2.1B | ||
| Q2 25 | $58.2M | $2.1B | ||
| Q1 25 | $60.2M | $2.1B | ||
| Q4 24 | $64.8M | $2.1B | ||
| Q3 24 | $60.7M | $2.1B | ||
| Q2 24 | $65.4M | $2.0B | ||
| Q1 24 | $70.7M | $2.0B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $18.7M |
| Free Cash FlowOCF − Capex | $-2.8M | $18.2M |
| FCF MarginFCF / Revenue | -14.6% | 115.6% |
| Capex IntensityCapex / Revenue | 1.4% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 3.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $33.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $18.7M | ||
| Q3 25 | $-3.5M | $5.5M | ||
| Q2 25 | $-1.2M | $8.0M | ||
| Q1 25 | $-702.0K | $2.2M | ||
| Q4 24 | $-2.9M | $14.2M | ||
| Q3 24 | $-4.4M | $-1.3M | ||
| Q2 24 | $-4.3M | $4.0M | ||
| Q1 24 | $-6.3M | $-1.2M |
| Q4 25 | $-2.8M | $18.2M | ||
| Q3 25 | $-4.1M | $5.2M | ||
| Q2 25 | $-1.5M | $7.8M | ||
| Q1 25 | $-757.0K | $2.2M | ||
| Q4 24 | $-3.2M | $13.9M | ||
| Q3 24 | $-4.6M | $-1.3M | ||
| Q2 24 | $-4.6M | $4.0M | ||
| Q1 24 | $-6.4M | $-1.2M |
| Q4 25 | -14.6% | 115.6% | ||
| Q3 25 | -31.5% | 33.6% | ||
| Q2 25 | -13.2% | 50.3% | ||
| Q1 25 | -8.0% | 15.2% | ||
| Q4 24 | -22.4% | 99.6% | ||
| Q3 24 | -40.0% | -9.9% | ||
| Q2 24 | -38.0% | 31.6% | ||
| Q1 24 | -62.2% | -9.5% |
| Q4 25 | 1.4% | 3.1% | ||
| Q3 25 | 4.0% | 1.7% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 0.6% | 0.4% | ||
| Q4 24 | 1.7% | 1.9% | ||
| Q3 24 | 1.3% | 0.2% | ||
| Q2 24 | 2.4% | 0.1% | ||
| Q1 24 | 0.3% | 0.0% |
| Q4 25 | — | 3.26× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 3.21× | ||
| Q3 24 | — | -0.30× | ||
| Q2 24 | — | 2.35× | ||
| Q1 24 | — | -0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
